Reproductive and behavioral effects of diisononyl phthalate (DINP) in perinatally exposed rats by Boberg, Julie et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 18, 2017
Reproductive and behavioral effects of diisononyl phthalate (DINP) in perinatally
exposed rats
Boberg, Julie; Christiansen, Sofie; Petersen, Marta Axelstad; Kledal, Thuri Seidler; Vinggaard, Anne
Marie; Dalgaard, Majken; Nellemann, Christine; Hass, Ulla
Published in:
Reproductive Toxicology
Link to article, DOI:
10.1016/j.reprotox.2010.11.001
Publication date:
2011
Link back to DTU Orbit
Citation (APA):
Boberg, J., Christiansen, S., Petersen, M. A., Kledal, T. S., Vinggaard, A. M., Dalgaard, M., ... Hass, U. (2011).
Reproductive and behavioral effects of diisononyl phthalate (DINP) in perinatally exposed rats. Reproductive
Toxicology, 31(2), 200-209. DOI: 10.1016/j.reprotox.2010.11.001
Accepted Manuscript
Title: Reproductive and behavioral effects of Diisononyl
phthalate (DINP) in perinatally exposed rats
Authors: Julie Boberg, Sofie Christiansen, Marta Axelstad,
Thuri Seidler Kledal, Anne Marie Vinggaard, Majken
Dalgaard, Christine Nellemann, Ulla Hass
PII: S0890-6238(10)00325-4
DOI: doi:10.1016/j.reprotox.2010.11.001
Reference: RTX 6472
To appear in: Reproductive Toxicology
Received date: 27-8-2010
Revised date: 20-10-2010
Accepted date: 5-11-2010
Please cite this article as: Boberg J, Christiansen S, Axelstad M, Kledal TS, Vinggaard
AM, Dalgaard M, Nellemann C, Hass U, Reproductive and behavioral effects of
Diisononyl phthalate (DINP) in perinatally exposed rats, Reproductive Toxicology
(2010), doi:10.1016/j.reprotox.2010.11.001
This is a PDF file of an unedited manuscript that has been accepted for publication.
As a service to our customers we are providing this early version of the manuscript.
The manuscript will undergo copyediting, typesetting, and review of the resulting proof
before it is published in its final form. Please note that during the production process
errors may be discovered which could affect the content, and all legal disclaimers that
apply to the journal pertain.
Page 1 of 36
Ac
ce
pte
d M
an
us
cri
pt
Anti-androgenic effects of DINP                  1 
 
 
Reproductive and behavioral effects of Diisononyl phthalate (DINP) in perinatally exposed rats 
 
Julie Boberg, Sofie Christiansen, Marta Axelstad, Thuri Seidler Kledal, Anne Marie Vinggaard, 
Majken Dalgaard, Christine Nellemann, Ulla Hass. 
 
Division of Toxicology and Risk Assessment, National Food Institute, Technical University of 
Denmark, Mørkhøj Bygade 19, DK-2860 Søborg, Denmark. 
 
Corresponding author: Julie Boberg, jubo@food.dtu.dk; Tel +45 3588 7560, fax +45 3588 7001 
 
 
Page 2 of 36
Ac
ce
pte
d M
an
us
cri
pt
Anti-androgenic effects of DINP                  2 
Abstract  
Diisononyl phthalate (DINP) is a plasticizer abundantly used in consumer products as a substitute 
for other plasticizers prohibited in certain products due to reproductive toxicity. As anti-androgenic 
effects of DINP are suspected, DINP effects on reproduction and sexually dimorphic behaviour 
were studied.  
Pregnant Wistar rats were gavaged from gestation day 7 to postnatal day (PND) 17 with vehicle, 
300, 600, 750 or 900 mg DINP/kg bw/day.   
In fetal testes histopathological effects typical of phthalates were observed. In male offspring, DINP 
caused increased nipple retention, reduced anogenital distance, reduced sperm motility and 
increased sperm count. DINP affected spatial learning as female offspring performed better than 
controls and similarly to control males in the Morris Water Maze, indicating masculinization of 
behavior in DINP exposed females.  
These results show that DINP causes anti-androgenic effects on reproductive development, though 
less potent than DEHP, DBP and BBP, and further safety evaluation of DINP appears warranted.  
 
 
Keywords 
Phthalate, behavior, rat, semen quality, anti-androgenic, toxicity 
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Introduction  
Several papers have suggested that the observed increasing incidences of testicular cancer, 
hypospadia, cryptorchidism and reduced semen quality in recent years may be caused by endocrine 
disrupting environmental chemicals having adverse effects on male reproduction [1]. Among the 
chemicals suspected of causing these effects in humans are some of the abundantly used phthalates 
found in plastics, paints and other materials. Human studies have indicated associations between 
maternal exposure to some phthalates and altered reproductive development in their infant sons. 
Di(2-ethylhexyl) phthalate (DEHP), butylbenzyl phthalate (BBP), di-n-butyl phthalate (DBP) and 
diisobutyl phthalate (DiBP), are known to induce adverse effects in the reproductive system of male 
rats. Perinatal exposure to certain phthalates leads to anti-androgenic effects such as reduced 
anogenital distance (AGD), retained nipples, hypospadias, undescended testes, epididymal agenesis 
and low sperm counts in male rats [2-4]. These four phthalates have been classified for reproductive 
toxicity in the European Union, and are therefore prohibited for use in cosmetics, some food contact 
materials, toys and childcare articles. Data for diisononyl phthalate (DINP) have not been 
considered sufficient for a classification, but DINP is currently prohibited in toys to be placed in the 
mouth by children under the age of 3 [5]. Due to the restrictions on other phthalates, DINP is now 
the main plasticizer in Europe and the use of DINP and diisodecyl phthalate (DiDP) has increased 
from 35% to 65% of plasticizer consumption in Western Europe from 1999 to 2008 [6]. 
Gray et al., 2000, found that 750 mg/kg bw per day of DINP induced nipple retention in males after 
perinatal oral exposure of Sprague Dawley rats, whereas the same doses of DEHP and BBP  
induced other malformations in male offspring, clearly indicating that DEHP and BBP are more 
potent reproductive toxicants than DINP [3]. Waterman et al., 2000, performed a two-generation 
study in rats showing no effect of dietary DINP exposure on fertility, whereas AGD and nipple 
retention was not examined in that study [7]. Since then, two dose-response studies have examined 
the effects of dietary DINP exposure in rats. Masutomi et al., 2003, found reduced maternal weight 
gain, reduced postnatal weight gain and reduced body and testis weights before puberty, and slight 
testicular histological effects in adulthood after perinatal dietary exposure to DINP, but did not see 
any alteration of AGD [8]. These effects were seen at 20,000 ppm (corresponding to 1200-2600 
mg/kg bw per day), but not at 4,000 and 400 ppm (approx. 400 and 40 mg/kg). Lee et al., 2006, 
found reduced AGD and anogenital index (AGD divided by the cubic root of bodyweight) in all 
groups exposed via diet to DINP (40, 400, 4000 and 20000 ppm), whereas they did not detect any 
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change in anogenital index with exposure to di-n-butyl phthalate (DBP) [9]. None of these studies 
examined semen quality parameters or effects on the developing nervous system.  
A tight regulation of gonadal hormones is necessary for correct development of the central nervous 
system. Male and female rats are known to perform differently in a number of  behavioral tests [10] 
and some of the same gender differences are seen in humans [11].  Female rats show higher 
spontaneous activity than males and have a higher preference for sweetened water, while males 
generally perform better than females in spatial learning tests [11-16]. Severe alterations in sex 
hormone levels, caused by either castration, ovariectomy or exposure to estradiol or testosterone 
during critical periods of development affects a variety of these sexually dimorphic behaviors 
[12;17-19]. However, only a few papers have been published on how developmental exposure to 
environmental anti-androgens may affect these behaviors. Neonatal exposure to the pesticide 
prochloraz, an androgen receptor antagonist and steroid synthesis inhibitor, has been shown to 
increase sweet preference in males, while no effect was seen on female sweet preference [20]. The 
anti-androgen cyproteronacetat, an androgen receptor antagonist, improved female maze learning 
[18]. No published studies are available on the effects of DINP or other phthalates on motor activity 
levels, spatial learning or sweet preference, and in line with our hypothesis of anti-androgenic 
effects of DINP, we wished to examine whether perinatal DINP exposure affects sexually 
dimorphic behavior in these tests.  
 
Based on the indications of anti-androgenic effects of DINP and other phthalates and on the limited 
knowledge on how anti-androgens including phthalates may influence behavior, we aimed to 
investigate reproductive and behavioral effects of perinatal DINP exposure in rats. The current 
study was designed to provide improved dose-response data on the influence of DINP on androgen 
dependent endpoints. A small subfraction of litters were used for studying mechanisms of action in 
fetal testes, as some phthalates are known to reduce testosterone production in late gestation [21-
23]. Pregnant and lactating Wistar rats were gavaged with 0, 300, 600, 750 and 900 mg/kg bw per 
day of DINP from GD 7 to PND 17 and several hormone-sensitive endpoints were examined in 
fetuses, pups and in adult offspring, including semen quality parameters and sexually dimorphic 
behavior.  
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Materials & Methods 
Test compounds: DINP, diisononyl phthalate, CAS No 28553-12-0, purity 99% was from Aldrich 
37,666-3.  
Animals and dosing: 80 time-mated Wistar rats (HanTac:WH, Taconic M&B, Denmark, body 
weight approx. 200 g) were supplied at day 3 of pregnancy. The animals were received in two 
blocks of 40 rats separated by one week. The day following mating was designated GD 1, and PND 
1 was the day following birth. The dams were randomized into five groups of 16 with similar body 
weight distributions and housed in pairs until GD 21 under standard conditions. Semi-transparent 
plastic cages with pinewood bedding were situated in an animal room with controlled 
environmental conditions (12 h light-dark cycles with light starting at 9 p.m., light intensity 500 lux, 
temperature 22 ± 2°C, humidity 55% ± 5%, ventilation 10 air changes per h). Food (Altromin 
Standard diet 1314) and tap water were provided ad libitum. The animals were dosed with vehicle 
(corn oil from Sigma), 300, 600, 750 or 900 mg DINP/kg bw per day from GD 7 to PND 17. 
Animals were inspected for signs of general toxicity twice daily. These doses are comparable to 
doses used in other studies on DINP [3;7]. 
Subgroup 1: Caesarian section and investigation of fetal testosterone production and testicular 
histopathology  
On GD 21, 4 dams per group were anesthetized in CO2/O2 and decapitated, and fetuses were 
removed and decapitated. Testes were removed and sampled for histopathology, measurement of 
testosterone production ex vivo, or measurement of testosterone content. One or two testes per litter 
were placed in modified Davidson’s fixative, and one testis per litter was placed in neutral buffered 
formaldehyde for histopathology and immunohistochemistry. Assessment of testosterone 
production ex vivo was performed on one testis from two pups per litter as described in [21] by 
incubating testes for 3 hours at 37°C in media containing 1 IU/ml of human chorion gonadotropin. 
Another testis per litter was placed in an empty tube and immediately frozen in liquid nitrogen and 
stored at –80C until analysis. Testosterone was extracted by two consecutive diethylether 
extraction procedures and stored at –80C until analysis.  
Hormone analysis: Trunk blood from all males was collected with heparinized microfuge tubes and 
kept on ice. Pools of blood from each group was centrifuged at 4000 g for 10 min at 4˚C, and kept 
at -80ºC until analysis of testosterone content. Steroids were extracted from plasma samples by 
solid-phase extraction using IST Isolute C18 SPE columns of 100 mg. Testosterone content in 
incubation media, testes and plasma was analyzed with a Delfia time-resolved fluoroimmunoassay 
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(PerkinElmer, Wallac Oy, Turku, Finland). The detection limit of the assay is 0.3 nM and intra-
assay variability is reported to 5.5-6% by the supplier. Plasma LH was measured using the time-
resolved fluorimetric assay (Delfia, Wallac OY, Turku, Finland), see[24] for specifications.  
Histology: Sections of reproductive organs and thyroids were stained with haematoxylin and eosin 
for histopathological evaluation blinded to the observer.  
 
Subgroup 2: Pregnancy and postnatal development 
After birth (PND 1), dams and all live pups in the litter were weighed. Pups were sexed and the 
anogenital distance (AGD) was measured using a stereomicroscope. This distance is normally 
approximately twice as long in male as in female control offspring but can be reduced in males by 
anti-androgenic chemicals. At PND 13 all pups were weighted and examined for the presence of 
nipples/areolas, described as a dark focal area (with or without a nipple bud) located where nipples 
are normally present in female offspring. The nipples were counted and no distinction was made 
between the retention of an areola or a nipple. The number of nipples in female rats is normally 12-
13 versus zero in males. AGD and NR was recorded by the same technician blinded to exposure 
group. 
Maternal pup retrieval, a test of interaction between mother and pups, was assessed on PND 1 in all 
dams. The dams were removed from their cage while three pups were moved from the nest to the 
corner of the cage diagonal to the nest, and the time the dam used to carry the pups back to the nest 
was recorded. The test was stopped if the dam had not retrieved her offspring within three minutes. 
At weaning (PND 21), pups were divided into two subgroups depending on their use for further 
studies. In all weaned offspring, age at sexual maturation was investigated by recording the day of 
vaginal opening in the females and cleavage of the balano-preputial skinfold in the males. The latter 
was done by observing when the prepuce, which is fused to the glans penis until the onset of 
puberty, could be fully retracted. 
Subgroup 2a: Reproductive organs and semen quality in adulthood: 
Tail blood was collected on PND 22 for Inhibin B analysis as described by [21]. 
Autopsy PND 90, males: 1-7 males per litter were anesthetized in CO2/O2 and blood samples were 
collected in heparinized tubes for hormone analysis. Males were examined for presence of nipples, 
penile malformations and testicular descent. 
The following organs were excised and weighed: liver, kidney, adrenal, thyroid, right and left testis, 
left epididymis, seminal vesicle, ventral prostate, levator ani/bulbocavernosus muscle (LABC), 
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bulbouretral gland. From all males one testis was fixed in modified Davidson’s fixative for 
histopathology (alternately right and left testis). The contralateral testis was frozen for hormone 
analysis. 
Testes for histopathology were processed after 24 hours and paraffin embedded and stained with 
hematoxylin and eosin, whereas all other organs were stored in formalin for later processing. Semen 
quality analysis was performed on 1-3 males per litter, and from further 1 to 3 males per litter, 
epididymides were fixed in formalin for histopathology. For semen quality analysis, the 
epididymides were removed and the cauda of the right epididymis was used for motility analysis. 
The cauda of the left epididymis was frozen in liquid nitrogen for later sperm count.  
The right epididymis was trimmed of fat and cauda was placed in warm (37 °C) Medium 199 Hanks 
& Hepes (Invitrogen Life Technologies, Denmark), supplemented with 0.5% bovine serum albumin 
(Sigma Chemical Company, St. Louis, MO). Spermatozoa were obtained from the distal cauda 
where the tubular diameter is widest. Under the dissecting microscope, the cauda was held by 
forceps and several stabs were made into the tubules. The petri dish was placed in an incubator for 
5 min. Cauda was removed and the sperm sample was diluted 10 times (in medium 199, 
supplemented with 0.5% bovine serum) and re-placed in the incubator for 10 min, to allow 
dispersion of spermatozoa. Sperm
 
samples were analyzed by computer-assisted sperm analysis 
(CASA;
 
HTM-IVOS version 12 Hamilton Thorne Research, Beverly, MA).
 
The parameters 
evaluated were percent motile and progressive sperm and sperm
 
velocities. Cauda of the left 
epididymis was thawed at room temperature,
 
trimmed of fat, weighed, and homogenized in 1 ml 
Triton X-100.
 
The homogenate was treated with ultrasonic sound and placed
 
into a stain reaction 
vial containing DNA-specific fluorescent
 
stain (Supra Vital IDENT Stain Kit, HTR). Sperm 
samples were
 
placed in the HTM-IVOS. Samples were analyzed by CASA, counts
 
were averaged, 
and the data were presented as number of sperm
 
per gram cauda. 
Autopsy PND 90, females.  Females were autopsied on the day of estrus as determined by 
evaluation of vaginal smears. Uteri and ovaries were excised and weighed.  
 
Subgroup 2b: Behavior 
One or two male and female pups from each litter were weaned at PND 21 and used for behavioral 
testing.  All animals from this group were sacrificed at approximately PND 200. The presence of 
malformations of external genitals and nipple retention in the males was investigated. 
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Motor activity and habituation capability. Motor activity levels of the rat offspring were recorded 
at 4 weeks (PND 27/28) of age and in adults (PND 11-12 weeks old). At testing, the animals were 
placed individually in clean plastic cages without bedding, and the cages were placed in activity 
boxes with photocells that measured horizontal activity for 30 min as described in Axelstad et al., 
2008 [25].  
Morris maze Learning and memory. The testing in Morris water maze has been described earlier 
by Hass et al.1995, and Axelstad et al. 2008 and was carried out when the rats were 2-3 months of 
age [25;26]. The pool had a diameter of 220 cm, and was situated in a laboratory measuring 4.5 x 6 
m with a number of spatial cues on the surrounding walls (geometric shapes approximately one 
meter in height, posters and lockers), in order for the rats to triangulate their position. In the pool, a 
circular transparent platform was situated on a solid support and submerged 1 cm below the water 
surface, thus invisible from water level. The animals were tested in four daily trials using four 
different starting points along the rim of the pool. When the rats reached and climbed onto the 
platform, the trial was completed. If the animal failed to locate the platform within 60 s, it was led 
to the platform and 60s were registered as time.  A video-tracking device (Viewpoint video tracking 
system, Sandown Scientific, Middlesex, England) tracked the route of the animals, and the latency 
to find the platform, the swim length, and swim speed were used as endpoints. All tests were 
performed in dim lighting and the following scheme was used:  
Learning: With the platform situated at the same place, the animals were trained in four trials per 
day for 5 consecutive days, until a stable performance was established. 
Memory:  Four weeks after the learning period, the animals were tested again with the platform still 
in the same position in the pool. The animals were given four trials on each of 2 consecutive days. 
New platform position (reversal learning and new learning): The day after the memory testing, the 
animals were tested in a reversal procedure (reversal learning) with the platform placed opposite to 
the original location. The following day, the platform was located in the centre of the maze (new 
learning). In both tests the animals were tested for four trials. 
 
Sweet preference testing was performed at 4 months of age. The weeks before testing, the animals 
were housed one per cage, and habituated to drinking from two bottles with tap water. During the 
week of testing the animals were given a choice between tap water and water sweetened with 0.25% 
saccharin (Sigma-Aldrich). Position of the saccharin and water bottles were counterbalanced in 
each group to avoid position preferences. Each day the intake from both bottles was measured, and 
Page 9 of 36
Ac
ce
pte
d M
an
us
cri
pt
Anti-androgenic effects of DINP                  9 
the bottles were refilled if needed. Body weights were registered in the same week and used for 
calculation of saccharin intake per 100 g body weight. 
 
Radial arm maze. At the age of 5-7 months, the subgroup 2b animals, were tested in a standard 8-
arm Radial Arm Maze (RAM). This test of spatial learning and memory ability consists of a maze 
elevated 90 cm above the floor with 8 arms radiating from a central area. At the end of each arm a 
reward is placed and photocells register the rat’s movement in the maze as it searches for rewards. 
The testing procedure is described further in[25].  
  
 
Statistical analysis. Data were examined for normal distribution and homogeneity of variance, and 
data were ln-transformed when relevant. In cases where normal distribution and homogeneity of 
variance could not be obtained by data transformation, a non-parametric Kruskall-Wallis test was 
used, followed by Wilcoxon’s test for pair wise comparison. 
Statistical analysis of the effect of DINP dosing on macroscopic lesions and histopathology, were 
done using Fisher’s Exact Test.  
When more than one pup from each litter was examined, statistical analyses was adjusted using 
litter as an independent, random and nested factor in ANOVA. Dunnett’s test was performed to 
determine differences between treated and control group means. Data analysis of AGD included 
body weight as a covariate in the analysis, to correct for the relationship between body size and 
AGD. In the analysis of organ weights, body weight was used as a covariate, and in the analysis of 
pup weight at birth, PND 6 and PND 13 the number of animals per litter was used as a covariate.  
Generalized linear models (GLM) in combination with generalized estimating equations in order to 
account for the nested litter correlation analyzed the number of nipples. P-value adjustments were 
carried out by the ROM procedure, a powerful step-up procedure for protecting the global error rate 
α= 5% [27]. Asterisks in tables and figures, indicate a statistically significant difference compared 
to controls *: p≤ 0.05; **: p< 0.01. Statistical analyses were done using the SAS procedure PROC 
GLM and PROC MIXED (SAS version 8, SAS Institute Inc, Cary, NC, USA).  
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Results 
 
Subgroup 1: Caesarian section and investigation of fetal testosterone production and testicular 
histopathology 
Testicular histology was affected in all dose groups, with all examined animals affected in the two 
highest dose groups. Multinucleated germ cells were seen in some animals from the lowest dose 
group, and the percentage of affected animals increased with higher doses. In the two highest dose 
groups, most testes appeared to have an increased number of gonocytes with a central location in 
seminiferous chords, and chord diameters were significantly increased (Figure 1, Table 1). It should 
be noted that only one section from each of 5 to 7 testes representing 3 to 4 litters were investigated. 
A tendency towards reduced testicular testosterone production ex vivo was seen in the DINP 
exposed groups, but this was not statistically significant (p=0.08, 0.11 and 0.07 in the three highest 
dose groups, respectively) (Figure 2A). Testicular testosterone content was significantly reduced in 
the group exposed to 600 mg/kg bw per day of DINP (p=0.044) and a slight but not statistically 
significant reduction was seen in the highest dose group (p=0.099, Figure 2B). Plasma testosterone 
or LH levels were not significantly different between groups (Figure 2C and D). It should be noted 
that only a small number of samples were used for hormone analyses due to few litters (n=3-4) 
available for caesarean section.  
 
Subgroup 2: Pregnancy and postnatal development  
Maternal body weight and weight gain during pregnancy was unaffected by treatment (Table 2). 
No changes in gestation length, postimplantation loss, litter size, sex ratio or perinatal loss were 
seen (Table 2).  
 
Anogenital distance in male pups on PND 1 was reduced dose-dependently by DINP compared to 
controls (Table 3 and Figure 3). As the anogenital distance depends on the size of the animal, 
corrections for body weight were made by including birth weight as a covariate in the statistical 
analysis. Uncorrected anogenital distances were significantly lower at the three highest doses, but 
when including birth weight as a covariate the anogenital distance reduction was only statistically 
significant in males exposed to 900 mg/kg of DINP (Figure 3, Table 3). Also the “anogenital 
index”, i.e. anogenital distance divided by the cubic root of the body weight was statistically 
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significantly lower in the highest dose group. No statistically significant differences in birth weigths 
were observed, although DINP exposed males appeared slightly smaller (Table 3). 
No change in female anogenital distance or birth weight was detected (Table 3). 
Body weight at PND 13 was significantly reduced at 900 mg/kg bw per day in males and at 750 
mg/kg bw per day in females (Table 3). A statistically significant and dose-dependent increase in 
nipple retention in male pups was seen at 750 and 900mg/kg bw per day, with a borderline 
significant increase in nipple retention at 600 mg/kg bw per day (adjusted p=0.058) (Figure 3, Table 
3).  
Pup retrieval time, and age and weight at sexual maturation were unaltered by treatment (data not 
shown).  
 
Subgroup 2a: Reproductive organ studies and semen quality analysis in adulthood 
Genital malformations and nipple retention at autopsy  
At PND 90 two control males had one nipple each and three males per group from the three highest 
dose groups had one to six nipples each. Of these, two animals from group DINP 600 and 750, 
respectively, had 4 and 6 thoracic nipples. There was no statistically significant difference between 
groups in the number of nipples or in anogenital distance at PND 90. 
 
Organ weights PND 90 males and females 
Weights of livers, thyroids and reproductive organs of males and females were not altered by 
treatment (Table 4). It was noted that one male from the DINP 600 group and one male from the 
DINP 750 group had small testes and epididymides. 
 
Histopathology PND 90 
Histology of male reproductive organs at PND 90 was not altered by DINP treatment (Table 5). 
Seminal vesicles showed few and insignificant findings and prostates showed more frequent 
alterations such as edema and leucocyte infiltration, but these alterations were also seen in controls 
and did not appear dose-related.  
Testicular histology at PND 90 appeared unaffected although a few animals had small areas of 
tubular degeneration in areas of focal Leydig cell hyperplasia.  
No consistent changes in the histology of adrenals, caput epididymis and thyroids were seen (data 
not shown). 
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Semen quality PND 90 
A dose-dependent reduction in the percentage of motile sperm was seen from 600 mg/kg bw per 
day (Figure 4). The percentage of motile sperm in the control group in the present study was well 
within the historical control range in our lab [4;25;28].The percentage of progressive sperm was 
statistically significant in the 750 DINP group, in which one animal had very low sperm motility. 
This animal also had small testes and epididymides. When this animal was taken out of the 
statistical analysis, there were no longer significant effects of treatment on the percentage of 
progressive sperm. Sperm velocity parameters were not affected by DINP treatment but sperm 
count measured by IDENT was significantly higher in the highest dose group when analyzed both 
with and without the outlier mentioned above (Figure 4). This 17% increase in sperm count per 
gram cauda epididymis reflected a 9% increase in sperm counts per sample and a 7% decrease in 
cauda epididymis weight in the highest dose group compared to controls, although these differences 
were not statistically significant.  
 
Hormone analysis PND 22 and 90 
Inhibin B is a hormone produced in Sertoli cells and may be used as an indicator of Sertoli cell 
number and function and serum levels peak around PND 22 [29]. In DINP exposed males, Inhibin 
B levels at PND 22 were comparable to control levels (Table 4). 
Mean testicular testosterone content on PND 90 in the highest dose group was 63% of control 
levels, but this was not statistically significant, and no other differences between groups were 
observed  (Table 4). 
 
Subgroup 2b: Behavior 
Motor activity levels in young and adult offspring and radial arm maze performances were 
unaffected by DINP exposure in both male and female offspring (data not shown). 
The results from the sweet preference test are shown in Figure 5. There was a statistically 
significant sex difference in the total saccharin intake per gram body weight (p=0.04), as control 
females consumed approximately 25% more than control males. The saccharin consumption was 
unaffected by DINP exposure in male offspring, but was significantly elevated in females in the 750 
mg /kg bw per day group (p=0.03). The high saccharin intake in this group was mainly caused by 
three females from three different litters in this group having an intake that was approximately 30% 
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higher than the highest intakes among the other animals. As these values were plausible, they were 
not considered outliers. Elevated saccharin intake was, however, not seen in the highest dose group, 
and consequently the increased intake at 750 mg/kg bw per day might be a chance finding (Figure 
5). 
 
Results from the Morris Maze test are shown in figure 6 (A+B). Male performance during both the 
learning and memory period was unaffected by DINP exposure (data not shown). At the end of the 
learning period (day 5) and on the first day of memory testing there was a marked sex difference, as 
swim length and latency to reach the platform were almost twice as long in control females 
compared to control males. Both swim length and latency to reach the platform in the control group 
in the present study was well within the historical control range, as other studies in our laboratory 
have shown very similar values in the control group (unpublished data). On the first day of the 
memory testing, female performances showed a dose-dependent improvement, which was 
statistically significant in the high dose group for both swim length (p=0.039) and latency 
(p=0.040). This improved performance in the high dose females made their values similar to the 
male values. The differences between DINP exposed and control females was not significant on the 
second day of the memory testing or when the platform was moved to a new position in the maze 
(data not shown). 
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Discussion  
Human exposure to the plasticizer DINP is increasing as DINP is used as a substitute for DEHP, 
which is classified as a reproductive toxicant in the European Union and therefore prohibited for 
use in certain products. The current study revealed that developmental DINP exposure reduces 
anogenital distance, increases nipple retention and reduces sperm motility in adulthood in male 
offspring and alters sexually dimorphic behavior in female offspring. Additionally, histological 
changes typical of phthalate exposure were seen in fetal testes and tendencies towards reduced fetal 
testosterone levels were seen, although the group sizes (n=3-4 litters) for these investigations were 
small. These findings clearly indicate that DINP has similar effects on fetal testis histology, nipple 
retention and anogenital distance as those seen in numerous studies on DEHP and DBP [3;30;31], 
and further safety evaluation of the use of DINP is warranted. The current study further supports 
our previous study showing similar mechanisms of action  (i.e. reduction of fetal testosterone 
production) of DINP as DEHP [21]. A comparison of different phthalates in the Hershberger assay 
for anti-androgenic action also found similar effects of DINP as DEHP, BBP and DBP [32]. 
In the current study, DINP reduced sperm motility and increased prepubertal nipple retention from 
600 mg/kg bw per day, and a reduced AGD was seen in neonatal male rat pups at 900 mg/kg bw per 
day. These doses are high in comparison with DEHP, which increases nipple retention and reduces 
AGD from 10 mg/kg bw per day, and DBP which reduces AGD from 250 mg/kg bw per day 
[31;33-35], and DINP is thus less potent than DEHP and DBP.  
The production of DEHP is decreasing in Europe while still being abundantly used worldwide. 
However, as DEHP is mainly being replaced by DINP and diisodecyl phthalalate (DIDP), the use of 
DINP and DIDP now exceeds the use of DEHP threefold in Europe (ECPI homepage 
“phthtalates.com”). A human biomonitoring study showed a doubling of DINP exposure from 1988 
to 2003, and with the recent change in use pattern from DEHP to DINP in Europe the  risk of  
human DINP exposure may be rapidly increasing [36].  
Previous studies have shown anti-androgenic effects of DINP at 750 mg/kg bw per day [3;21], 
whereas renal and hepatic effects have been seen at lower doses in chronic studies (summarized in 
[37]). Lee et al., 2006, reported reductions in anogenital index from 40 ppm of DINP 
(approximately 5 mg/kg bw per day), but as they reported n=16 to 47, the applied statistics were 
probably based on single offspring instead of using litters as the statistical units [9]. An analysis of 
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their data including consideration of litter effect would be required to determine the doses inducing 
statistically significant changes in anogenital index.  
This is the first study to investigate effects of DINP on the development of sexually dimorphic 
behaviors.  In the Morris water maze, which is a test investigating spatial learning and memory 
abilities, DINP exposed females showed a dose-dependent improvement, which was statistically 
significant in the highest dose group on the first day of memory testing. This improved performance 
in the high dose females made their performance similar to the male performance, and may 
therefore indicate masculinization of the brain in the high dose females. This was surprising as our 
own studies on female sexually dimorphic behavior in rats developmentally exposed to other anti-
androgenic compounds including DEHP have not shown similar effects as presented here for DINP 
[39]. However, indications of masculinization of female learning behavior has been seen in 
previous studies after endocrine disruption during the critical periods of brain development, as 
treatment with both testosterone and the anti-androgen cyproteronacetat, an androgen receptor 
antagonist, improved female maze learning [17;18;38]. It is difficult to explain why both androgens 
and anti-androgens affect female maze learning in the same direction, but it appears that hormonal 
imbalance during the critical periods of brain development is sufficient to alter the default female 
outcome in a more masculine direction. Our study on DEHP showing no effect on female sexually 
dimorphic behaviors, however, included only one dose level of 100 mg/kg bw per day whereas the 
effect seen in this DINP study was statistically significant at 900 mg/kg bw per day.  Effects of 
DINP on female behavior were not observed on the other test days in the Morris water maze, or in 
the other behavioral tests performed in the current study. Consequently, there is a need for further 
studies to elucidate the implications of the observed significant effect of DINP on female memory.   
 
Saccharin intake appeared to be increased in females in the second-highest dose group, but not in 
the highest dose group and this may be a chance finding. A previous study of developmental 
exposure to a mixture of four anti-androgenic compounds (DEHP, Prochloraz, Vinclozolin and 
Finasteride) on female behavior has shown an increased intake of sweet water compared to control 
females [39]. If the observed increase in saccharin intake in DINP exposed animals is real, this 
finding further emphasizes that DINP acts similarly as other known anti-androgenic chemicals. 
However, as a high saccharin intake is regarded as a female characteristic in rats, this could be 
interpreted as polarization of sexual development (feminization of females), which is in contrast to 
the equalization of sexual differences observed with the other findings in the current study. It has 
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previously been reported that anti-androgenic chemicals, e.g. the fungicide Prochloraz, can increase 
the sweet preference of males [20], but no changes in male sweet preference were found in the 
current study.  
 
This is also the first study to investigate effects of DINP on semen quality. Interestingly, DINP 
dose-dependently reduced the percentage of motile sperm in the three highest dose groups, and a 
slight reduction in the percentage of progressive sperm was noted. Velocity parameters were not 
altered despite the observed reduction in the percentage of motile sperm. However, velocity 
parameters appeared rather insensitive as the one animal in the DINP 750 group with a very low 
sperm count and a low percentage of motile sperm had normal values of the four velocity 
parameters. In the highest dose group, a statistically significant increase in sperm counts measured 
as sperm per g cauda epididymis (p=0.048) was observed, but as sperm count per sample was 
slightly increased and cauda epididymis weight slightly reduced, this may reflect a change in 
epididymal development caused by DINP. In combination with the finding of reduced sperm 
motility, these data may indicate that DINP does not affect testicular sperm production, but may 
rather affect epididymal function and sperm maturation. As no changes in epididymal 
histopathology was observed, further analyses are needed to elucidate the effects of DINP on 
epididymis function and sperm maturation. 
No changes in testicular histopathology were noted at PND 90 in the current study. Masutomi et al., 
2003, reported slight Sertoli cell and spermatocyte degeneration together with debris in epididymal 
ducts in rats exposed to higher doses (1200-2600 mg/kg bw per day) of DINP [8]. A two-generation 
reproduction study on dietary DINP exposure showed no effects on fertility or testis histology, but 
did not examine semen quality parameters or anti-androgenic endpoints such as nipple retention and 
anogenital distance [7]. The lack of reproductive effects in that study is not in conflict with our 
finding of reduced sperm motility, as semen quality in rats may be affected without influencing 
fertility in rats [40;41]. In humans, on the other hand, reproduction is less robust than in the rat, and 
effects of DINP on sperm motility in humans may thus affect fertility although such an effect is not 
seen in rats [40;41].  
DINP is a mixture of isomers, and two different CAS numbers for DINP exist covering variants of 
DINP produced by different processes and with different composition. DINP1 has CAS no 68515-
48-0 and DINP2 has CAS no 28553-12-0, and in the EU risk assessment, these different mixtures of 
isomers are evaluated together although differences in toxicity and physico-chemical properties 
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may occur. The Waterman study used dietary DINP1 exposure throughout life while we studied 
perinatal exposure to DINP2 by gavage. Overall, the effects of DINP1 and DINP2 do not appear to 
differ significantly, as this and other studies on DINP2 [8;9;21] reveals comparable effects to those 
seen with DINP1 in the study by Gray et al., 2000. 
In the present study, four DINP exposed animals had permanent malformations such as epididymal 
and testicular dysgenesis and permanent nipples. One animal from each of the groups exposed to 
600 and 750 mg/kg bw per day of DINP had very small testes and epididymides. Additionally, two 
other males exposed to 600 and 750 mg/kg/day of DINP, had 4 and 6 thoracic nipples, respectively.  
These findings are comparable to the results reported in a study by Gray et al., 2000, in Sprague-
Dawley rats. They reported malformations (permanently retained nipples and testicular and 
epididymal abnormalities) in 4 of 52 male pups from 3 of 14 litters exposed to 750 mg/kg bw per 
day of DINP [3]. In our study in Wistar rats, we examined 35, 18 and 22 males from 10, 7 and 8 
litters in the three dose groups exposed to 600, 750 and 900 mg/kg bw per day. Thus, the incidence 
of permanent malformations was slightly lower in our study (4 of 75 males exposed to 600 mg/kg 
or more, and 2 of 40 males exposed to 750 mg/kg or more) than in the study by Gray et al., 2000, (4 
of 52 males exposed to 750 mg/kg). Similarly, our comparable studies with DEHP in Wistar rats 
have shown that late adverse reproductive effects (i.e. testicular and epididymal abnormalities) are 
seen only in a subgroup of animals, whereas the majority of animals appear to regain full function 
also after DEHP exposure [4]. In the paper by Gray et al., 2000, the same dose of DEHP and BBP 
(750 mg/kg bw/day) induced a notably higher incidence of malformations including nipples, cleft 
phallus, hyperspadias, and agenesis of reproductive organs in male offspring than DINP did, 
showing that DINP is a less potent reproductive toxicant than DEHP and BBP [3].  
No permanent changes in AGD were detectable, but as DINP appears to be a weaker anti-androgen 
than other phthalates, only slight alterations in adult AGD would be expected for DINP. Permanent 
changes of AGD have been observed in studies with more potent anti-androgens such as the 
herbicide linuron [42]. In that paper, BBP decreased AGD in the neonatate and not in the adult. 
Only when rats were exposed to BBP and linuron in combination, a the reduction in AGD observed 
in neonates persisted to adulthood [42]. However, the transient nature of the changes in AGD, 
nipple retention and testicular effects observed with DINP should not lead to the misinterpretation 
that these effects are unimportant. On contrary, the association of these early markers of endocrine 
disruption with adverse effects such as permanent malformations and disruption of the reproductive 
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system has been shown in several studies [30;42-44] including the current study showing permanent 
alterations of semen quality and sexually dimorphic behavior.  
Our own previous data showed reduction of fetal testicular testosterone level and –production at 
750 mg/kg bw per day of DINP, and accumulative effects with combined exposure to DEHP [21]. 
In the current study, effects of DINP on fetal testosterone was only borderline significant, probably 
due to the small number of litters sampled for these endpoints. In both studies, changes in fetal 
testicular histopathology were observed, i.e. presence of multinucleated germ cells and enlarged 
seminiferous chords with centrally located gonocytes [45]. These changes are also seen with fetal 
exposure to DEHP and DBP, and these abnormalities show certain parallels to human testis cancer 
and the human testicular dysgenesis syndrome [46;47]. Further immunohistochemical analyses on 
fetal testes from the combination study on DEHP and DINP revealed that DINP reduced staining 
intensity for the steroidogenic factors StAR, P450scc and CYP17 in a similar manner as DEHP 
[48]. This indicates that DINP has a similar mechanism of action as DEHP and DBP, as the 
reduction of factors involved in steroid synthesis leads to reduced fetal testosterone levels as shown 
in several studies [49-51].  
In contrast to our study, Adamsson et al., 2009, found no change in testosterone production of fetal 
testes at GD 19 after exposure to 250 and 750 mg/kg bw per day of DINP from GD 13 to 17 [52]. In 
fact, they found increased mRNA levels of P450scc and Insl3, genes that are known to be reduced 
by other phthalates and that are likely involved in the anti-androgenic effects of these compounds 
[52]. This discrepancy between the results of the current study and the results reported by 
Adamsson et al., 2009, may be due to the fact that their study included a recovery period of two 
days between the last dosing and the time of examination. As the authors describe in their 
discussion, it is possible that the detected increase in P450scc and Insl3 is a “rebound effect” due to 
low testosterone production at the time of dosing a few days earlier [52]. 
 
In summary, our findings of similar dose-related effects (nipple retention, reduction of anogenital 
distance, disruption of semen quality) of DINP as previously seen with DEHP and DBP clearly 
support that DINP is an anti-androgen and a reproductive toxicant, but is less potent than DEHP and 
DBP. Furthermore, our study supports the previously reported findings of persistent malformations 
in DINP exposed males [3]. So far, DINP has not been classified for reproductive or developmental 
toxicity in EU although previous studies have shown anti-androgenic and reproductive effects of 
DINP. This study presents further evidence for grouping DINP with the other anti-androgenic and 
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reproductive toxic phthalates and will be useful for future risk assessments of DINP. This study also 
provides new knowledge on effects on sexually dimorphic behaviors indicating masculinization of 
behavior in DINP exposed females.  
In conclusion, a NOAEL of 300 mg/kg bw per day for reproductive toxicity and anti-androgenic 
effects can be set. As the use of DINP is currently increasing, it may be anticipated that the anti-
androgenic effect of DINP can be of importance for adverse endocrine disrupting and reproductive 
effects in humans, particularly as individuals are exposed to DINP in combination with several 
other anti-androgenic compounds present in the environment [53].  
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Figures 
 
Figure 1: Testicular histopathology at GD 21 in male rat fetuses exposed to 0 or 750 mg DINP/kg 
bw per day from GD 7 to GD 21. Multinucleated gonocytes (>) were present in testes of DINP-
exposed animals. Gonocytes were located centrally in the enlarged seminiferous chords. Original 
magnification 20x. 
Figure 2: Testosterone levels at GD 21 in male rat fetuses exposed to 0, 300, 600, 750 or 900 mg 
DINP/kg bw per day from GD 7 to GD 21. A) Testicular testosterone production ex vivo (n=3-4 
litters, 2 testes per litter), B) Testicular testosterone content (n=3-4 litters, 1-2 testes per litter), C) 
Plasma testosterone (n=3-4 samples pooled from each litter), D) Plasma LH (n=2-3 samples, each 
are pools of plasma from 1-2 litters). Mean + SEM, asterisks indicate a statistically significant 
difference compared to controls *:p<0.05.  
Figure 3.  Anogenital distance at birth and nipple retention on PND 13 in male offspring (n=7-10). 
Mean+SEM, * p < 0.05. 
Figure 4. Semen quality analysis in male 90-day old rats exposed to 0, 300, 600, 750 or 900 mg/kg 
bw per day of DINP from GD 7 to PND 17 (n=6-10). Mean+SEM, * p < 0.05, ** p<0.01.  
Figure 5. Male and female intake of saccharin in rats exposed to 0, 300, 600, 750 or 900 mg/kg bw 
per day of DINP from GD 7 to PND 17 (n=7-10 litters, 1-2 animals per litter). Mean and individual 
observations, * p < 0.05.  
Figure 6. Learning test in female rats exposed to 0, 300, 600, 750 or 900 mg/kg bw per day of DINP 
from GD 7 to PND 17 (n=7-10). Mean+SEM, * p < 0.05 compared to control females, #  p < 0.05 
control males compared to control females. A dose-related reduction in swim length (A) and latency 
(B) to reach the platform was seen in females with the highest dose group being significantly 
different from control females but comparable to control males.  
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Table 1. Testis histology GD 21 in rat fetuses exposed to 0, 300, 600, 750 or 900 mg/kg bw/day of DINP from GD 7 to 21. One testis 
section evaluated from 1 to 4 males per litter. Table lists: % affected, affected animals/total number of animals (affected litters/total number 
of litters). Results in bold are significantly different from controls in a one-sided Fisher’s exact test (p≤0.05). 
Testis histopathology GD 21  Control DINP 300 DINP 600 DINP 750 DINP 900
#
 
Total number of animals with histological 
changes 
  
Multinucleated gonocytes 
 
Many gonocytes with central location in chords 
 
Enlarged diameter of seminiferous chords 
0%,   0/7        
(0/3) 
 
0%,   0/7        
(0/3) 
 
0%,   0/7        
(0/3) 
 
0%,   0/7        
(0/3) 
25%, 2/8       
(2/4) 
 
25%, 2/8       
(2/4) 
 
0%, 0/8       
(0/4) 
 
0%, 0/8         
(0/4) 
60%, 3/5       
(2/3) 
 
60%, 3/5       
(3/3) 
 
40%, 2/5      
(2/3) 
 
40%, 2/5      
(2/3) 
100%, 7/7     
(3/3) 
 
86%, 6/7      
(3/3) 
 
86%, 6/7      
(3/3) 
 
57%, 4/7      
(1/3) 
100%, 6/6     
(3/3) 
 
100%, 6/6     
(3/3) 
 
80%, 4/5      
(2/2) 
 
60%, 3/5      
(2/2) 
 
# 
In one of the six animals evaluated in this group, the testis was damaged and testis histology could not be fully evaluated; however the 
presence of multinucleated gonocytes was noted.  
Tables
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Table 2. Pregnancy data for Wistar rats exposed to DINP from GD 7 to PND 17 (mean±SD). No statistically significant differences 
between groups were observed. 
 
 Control DINP 300 DINP 600 DINP 750 DINP 900 
Maternal bw gain, GD7-GD21 (g) 69.56±29.2 80.00±11.8 75.91±23.2 77.10±13.1 78.17±17.2 
Gestation length (days) 22.3±0.7 22.3±0.5 22.6±0.5 22.3±0.9 22.3±0.5 
No. of Fetuses 80 77 99 84 90 
No. of Litters 9 9 10 9 10 
Maternal body weight 233.9±10.6 234.6±13.7 231.7±7.6 236.4±7.0 224.5±12.0 
No. Implantations 10.1±4.6 10.1±1.1 11.5±1.8 10.4±3.7 11.0±2.7 
No. live fetuses 8.9±4.9 8.6±2.4 9.9±2.3 9.3±3.7 9.0±3.5 
% post-implantation loss   23.0±31.5 14.7±16.9 13.8±16.1 10.1±10.0 18.7±20.5 
Males in % of total 45.5±21.5 42.3±21.3 55.2±22.9 38.1±15.5 48.9±28.2 
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Table 3. Body weights, anogenital distance at birth  (AGD) and nipple retention on PND 13 for pups exposed to DINP from GD 7 to PND 
17 (mean ± SD). 
 
 Males Control DINP 300 DINP 600 DINP 750 DINP 900 
Birth weight
a
(g) 6.39±0.39 6.30±0.12 6.12±0.32 6.14±0.49 6.00±0.56 
Weight PND 13
a
(g) 28.64±5.21 28.60±2.99 27.44±2.25 26.25±3.58 25.57±2.96** 
AGD
a 
(units) 21.50±1.82 21.09±1.58 20.65±2.11 20.67±1.55 19.89±1.39* 
AGDi
b
  (units) 11.60±1.04 11.43±0.82 11.31±0.20 11.29±0.75 11.01±0.88* 
Nipples 1.98±0.83 2.00±0.64 2.91±0.69
c
 3.14±1.21* 3.17±0.92* 
 Females      
Birth weight
a
(g) 5.97±0.31 5.90±0.19 6.01±0.32 5.88±0.41 5.76±0.29 
Weight PND 13
a
(g) 29.49±4.69 27.93±2.53 26.47±2.49 24.40±4.62* 24.67±3.19
 d
 
AGD
a 
(units) 11.05±0.90 11.32±0.85 11.38±1.30 11.27±0.86 10.70±0.66 
AGDi
b
  (units) 6.10±0.50 6.27±0.48 6.26±.0.67 6.25±0.38 5.98±0.41 
Nipples 12.30±0.26 12.25±0.19 12.3±0.24 12.24±0.14 12.34±0.25 
a 
Analyzed with body weight as a covariate  
b 
AGDi is defined as AGD divided by the cube root of the body weight 
*ANOVA followed by Dunnett’s test p < 0.05. **ANOVA followed by Dunnett’s test p<0.01 
c ANOVA followed by Dunnett’s test p=0.058, 
d ANOVA followed by Dunnett’s test p=0.052   
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Table 4. Body weights, organ weights, anogenital distance (AGD) and testosterone levels in 90-day-old rats exposed to 0, 300, 600, 750 or 
900 mg/kg bw/day of DINP from GD 7 to PND 17. Serum Inhibin B levels in 22 day old rats. Body and organ weights are in grams and 
anogenital distance in cm. No statistically significant differences between groups were observed. For males n= 6-10 litters per group, 1-7 
males per litter (18-35 males per group). For females n= 6-8 litters, 1-2 females per litter (10 to 14 females per group). 
Males  Control DINP 300 DINP 600 DINP 750 DINP 900 
Body wt 
Liver 
Kidney 
Adrenals 
Thyroid 
Right testis 
Left testis 
Left epidididymis 
Prostate 
LABC 
Bulbourethral gland 
Seminal vesicle 
AGD 
Testis testosterone PND 90 
Serum inhibin B PND 22 
374.70 
11.96 
2.21 
0.058 
0.021 
1.85 
1.87 
0.58 
0.50 
1.03 
0.11 
1.40 
3.14 
43.9 
126 
±28.26 
±1.14 
±0.16 
±0.009 
±0.008 
±0.21 
±0.18 
±0.04 
±0.11 
±0.09 
±0.02 
±0.14 
±0.19 
±25.1 
±37 
378.53 
12.46 
2.18 
0.052 
0.026 
1.84 
1.86 
0.56 
0.50 
1.01 
0.12 
1.30 
3.15 
31.6 
123 
±29.45 
±1.17 
±0.22 
±0.007 
±0.018 
±0.16 
±0.17 
±0.04 
±0.08 
±0.07 
±0.03 
±0.21 
±0.22 
±19.4 
±36 
389.91 
12.92 
2.17 
0.051 
0.020 
1.92 
1.90 
0.58 
0.51 
0.97 
0.13 
1.39 
3.24 
50.3 
129 
±28.90 
±1.27 
±0.23 
±0.008 
±0.005 
±0.17 
±0.34 
±0.08 
±0.10 
±0.10 
±0.04 
±0.22 
±0.20 
±49.3 
±70 
368.17 
11.71 
2.19 
0.058 
0.028 
1.78 
1.82 
0.55 
0.48 
0.97 
0.13 
1.31 
3.12 
59.8 
111 
±32.56 
±1.27 
±0.28 
±0.010 
±0.016 
±0.11 
±0.13 
±0.05 
±0.10 
±0.11 
±0.03 
±0.14 
±0.20 
±53.6 
±30 
367.50 
11.42 
2.14 
0.051 
0.022 
1.85 
1.92 
0.58 
0.44 
0.96 
0.11 
1.34 
3.08 
27.6 
120 
±25.45 
±0.92 
±0.17 
±0.009 
±0.014 
±0.14 
±0.20 
±0.04 
±0.08 
±0.10 
±0.03 
±0.18 
±0.24 
±14.4 
±44 
Females           
Body wt 
Ovary 
Uterus 
213.9 
0.092 
0.466 
±9.73 
±0.011 
0.081 
236.54 
0.101 
0.501 
±35.56 
±0.018 
±0.093 
232.29 
0.100 
0.488 
±23.16 
±0.021 
±0.050 
218.58 
0.093 
0.503 
±16.33 
±0.012 
±0.044 
218.09 
0.108 
0.485 
±17.43 
±0.019 
±0.031 
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 Table 5. Histology of male reproductive organs at PND 90 in rats exposed to 0, 300, 600, 750 or 900 mg DINP/kg bw/day from GD 7 to 
PND 17. No significant differences between controls and DINP exposed groups were observed. Table lists: % affected, affected 
animals/total number of animals (the listed total number of animals examined represents 6 to 10 litters per group). No dose-related changes 
were observed on PND 90. 
Histopathology PND 90  Control DINP 300 DINP 600 DINP 750 DINP 900 
Seminal vesicle 
 Total number of animals with histological changes 
 Remains of epithelial cells in lumen of coagulating 
gland 
 Leucocytes in lumen of coagulating gland 
 
6%, 1/17  
6%, 1/17  
0% 
 
0% 
0% 
0% 
 
0% 
0% 
0% 
 
8%, 1/13  
0% 
8%, 1/13  
 
0% 
0% 
0% 
Prostate 
Total number of animals with histological changes 
 Edema 
 Leucocyte infiltration between acini 
 Acini with loosened epithelium 
 Acini not dilated by content 
 Leucocyte infiltration within acini 
 
33%, 6/18 
17%, 3/18 
22%, 4/18 
0% 
6%, 1/18 
6%, 1/18 
 
44%, 7/16 
13%, 2/16 
25%, 4/16 
6%, 1/16 
0% 
13%, 2/16 
 
44%, 7/16 
19%, 3/16 
31%, 5/16 
6%, 1/16 
13%, 2/16 
13%, 2/16 
 
54%, 7/13 
8%, 1/13 
38%, 5/13 
23%, 3/13 
15%, 2/13 
15%, 2/13 
 
29%, 4/14 
0% 
21%, 3/14 
0% 
0% 
7%, 1/14 
Testis 
Total number of animals with histological changes 
 Generalized or focal degeneration (>10% affected) 
 Malformed tubules in small Leydig cell clusters 
 Single tubules containing no spermatids 
 
30%, 7/23 
0% 
9%,   2/23  
22%, 5/23  
 
26%, 5/19  
0% 
0% 
26%, 5/19  
 
29%, 10/35  
0% 
9%,   3/35  
20%, 7/35  
 
11%, 2/18  
0% 
0% 
11%, 2/18  
 
6%, 1/18  
0% 
0% 
6%, 1/18  
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Figure 1
Click here to download high resolution image
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Figure 4
Click here to download high resolution image
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